Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
3
4
Next >
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
Walgreens Boots Alliance Inc
Business News
Amazon/com Inc
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
RayzeBio Inc
Business News
Roche Holding AG
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Amerisourcebergen Corp
Business News
Dell Technologies Inc
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Health & Science
Companies
Breaking News: Politics
From
CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
December 22, 2023
Tags
US: News
Goldman Sachs Group Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios
December 18, 2023
Tags
Investment Strategy
Mad Money
Kraft Heinz Co
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
Abbvie Inc
From
CNBC.com News
Jim Cramer explains why it's hard to be bullish on the healthcare sector
November 30, 2023
Tags
Business News
Business
Cigna Corp
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
CNBC Investing Club: Newsletter
Valley National Bancorp
Microsoft Corp
From
CNBC.com News
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
October 26, 2023
Tags
Pfizer Inc
Business News
Moderna Inc
From
CNBC.com News
Cramer's Lightning Round: Sell Fisker
October 23, 2023
Tags
Petroleo Brasileiro SA Petrobras
S&P 500
Business News
From
CNBC.com News
5 things to know before the stock market opens Monday
October 23, 2023
Tags
General Motors Co
Hess Corp
Coca/Cola Co
From
CNBC.com News
Top Wall Street analysts favor these five dividend stocks during tumultuous times
October 22, 2023
Tags
Chesapeake Energy Corp
EOG Resources Inc
Commentary
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Abbvie Inc
Novartis AG
AstraZeneca PLC
From
CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
Tags
Social issues
Biotech and Pharmaceuticals
Medicare Part D
From
CNBC.com News
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
September 27, 2023
Tags
Johnson & Johnson
Bristol/Myers Squibb Co
Pharmaceuticals
From
CNBC.com News
Top Wall Street analysts are bullish on these dividend stocks
September 24, 2023
Tags
U/S/ Markets
Broadcom Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Judge withdraws from Medicare drug price case after stock ownership is revealed
September 01, 2023
Tags
Policy
Business News
Politics
From
CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
Tags
Breaking News: Politics
Companies
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Wednesday
August 30, 2023
Tags
Business News
Politics
Coinbase Global Inc
From
CNBC.com News
Here are the three most used drugs on the Medicare price negotiation list
August 29, 2023
Tags
Pharmaceuticals
US: News
Bristol/Myers Squibb Co
From
CNBC.com News
Biden administration unveils first 10 drugs subject to Medicare price negotiations as it moves to cut costs
August 29, 2023
Tags
Health care costs
Health & Science
Breaking News: Politics
From
CNBC.com News
Why startups are investing millions to make drugs and semiconductors in space
August 20, 2023
Tags
COVID/19
Pfizer Inc
Redwire Corp
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Johnson & Johnson
Bristol/Myers Squibb Co
US: News
From
CNBC.com News
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
July 18, 2023
Tags
Bristol/Myers Squibb Co
Johnson & Johnson
US: News
From
CNBC.com News
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
June 30, 2023
Tags
Bristol/Myers Squibb Co
US: News
Coronavirus
From
CNBC.com News
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
June 21, 2023
Tickers
LAW
LAWS
Tags
Companies
Health & Science
Health care industry
From
CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
June 20, 2023
Tags
Breaking News: Business
Merck & Co Inc
Business
From
CNBC.com News
As the market starts to cool down, Cramer says don't be afraid to stay bullish
June 03, 2023
Tags
Tesla Inc
Merck & Co Inc
Brinker International Inc
From
CNBC.com News
Cramer's Lightning Round: Super Micro Computer is not a buy
May 30, 2023
Tags
Market Outlook
Business News
Business
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
